Outlook Therapeutics hires new SVP, marketing and market access
Alicia Tozier previously led launch teams at Genentech, Astellas and Baxter.
Stay updated with breaking news from Jeff Evanson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alicia Tozier previously led launch teams at Genentech, Astellas and Baxter.
NA Proactive news snapshot: BioHarvest Sciences, Marble Financial, ElectraMeccanica Vehicles, Ion Energy UPDATE … A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive BioHarvest Sciences Inc. (CSE:BHSC) (FRA:8MV) has announced the launch of direct-to-consumer sales of its flagship product VINIA in the United States, via its vinia.com website. After years of developing its BioFarming technology, the company said it is proud to bring the first product based on this technology to the US market...
Share: ISELIN, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced it will host a Virtual Clinical Day for analysts and accredited institutional investors with live video webcast (details below) on Thursday, May 20, 2021 from 11:00 AM – 1:00 PM ET. During the Virtual Clinical Day, Outlook Therapeutics will provide an overview of its lead program, ONS-5010 / LYTENAVA™ (bevaciz...
Outlook Therapeutics is hoping to become the first and only company to commercialize an FDA-approved ophthalmic formulation of bevacizumab for use in...